Not crushing on IPOs, Facebook's virtual strategy, a setback for Citi, and more.
StockInvestor editor Matt Coffina and senior biotech analyst Karen Andersen discuss Gilead's growing competitive advantages.
Our top managers continue to find attractive buying opportunities in wide-moat firms.
These three outstanding leaders have demonstrated sound stewardship practices for their firms' shareholders.
Hear industry outlooks and best ideas from the 12 Morningstar analysts named by The Wall Street Journal among the "Best on the Street."
A roundup of investment news.
Anxiety leads to sell-off--and some buying opportunities.
Three ways to separate long-term winners from stocks that fizzle.